UPL Ltd
UPL is principally engaged in the business of agrochemicals, industrial chemicals, chemical intermediates, speciality chemicals and production and sale of field crops and vegetable seeds.
- Market Cap ₹ 41,715 Cr.
- Current Price ₹ 556
- High / Low ₹ 625 / 448
- Stock P/E
- Book Value ₹ 359
- Dividend Yield 0.18 %
- ROCE 3.29 %
- ROE -4.28 %
- Face Value ₹ 2.00
Pros
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of 8.55% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Part of Nifty LargeMidcap 250 Nifty 200 Nifty Commodities BSE Allcap BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9,186 | 10,771 | 12,091 | 14,048 | 16,312 | 17,378 | 21,837 | 35,756 | 38,694 | 46,240 | 53,576 | 43,098 | 44,122 | |
7,531 | 8,753 | 9,728 | 11,700 | 13,346 | 13,966 | 18,024 | 28,984 | 30,342 | 36,711 | 43,380 | 38,801 | 39,921 | |
Operating Profit | 1,654 | 2,018 | 2,363 | 2,348 | 2,966 | 3,412 | 3,813 | 6,772 | 8,352 | 9,529 | 10,196 | 4,297 | 4,201 |
OPM % | 18% | 19% | 20% | 17% | 18% | 20% | 17% | 19% | 22% | 21% | 19% | 10% | 10% |
72 | 30 | -11 | 149 | 363 | 351 | -197 | -515 | 62 | 91 | 464 | 231 | 352 | |
Interest | 429 | 485 | 517 | 704 | 735 | 783 | 963 | 1,481 | 2,060 | 2,295 | 2,963 | 3,852 | 4,264 |
Depreciation | 354 | 407 | 425 | 676 | 672 | 675 | 880 | 2,012 | 2,173 | 2,359 | 2,547 | 2,763 | 2,827 |
Profit before tax | 944 | 1,157 | 1,410 | 1,117 | 1,922 | 2,305 | 1,773 | 2,764 | 4,181 | 4,966 | 5,150 | -2,087 | -2,538 |
Tax % | 22% | 19% | 17% | 15% | 10% | 12% | 11% | 21% | 16% | 11% | 14% | -10% | |
773 | 957 | 1,187 | 952 | 1,733 | 2,030 | 1,575 | 2,178 | 3,495 | 4,437 | 4,414 | -1,878 | -2,799 | |
EPS in Rs | 11.67 | 14.77 | 17.79 | 14.62 | 22.71 | 26.51 | 19.52 | 23.24 | 37.58 | 47.46 | 47.56 | -15.99 | -26.70 |
Dividend Payout % | 14% | 18% | 19% | 23% | 20% | 20% | 27% | 26% | 27% | 21% | 21% | -6% |
Compounded Sales Growth | |
---|---|
10 Years: | 15% |
5 Years: | 15% |
3 Years: | 4% |
TTM: | -11% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -226% |
Stock Price CAGR | |
---|---|
10 Years: | 9% |
5 Years: | 1% |
3 Years: | -8% |
1 Year: | -2% |
Return on Equity | |
---|---|
10 Years: | 13% |
5 Years: | 10% |
3 Years: | 9% |
Last Year: | -4% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 89 | 86 | 86 | 86 | 101 | 102 | 102 | 153 | 153 | 153 | 150 | 150 | 150 |
Reserves | 4,557 | 5,162 | 5,775 | 5,803 | 7,214 | 9,067 | 14,613 | 19,129 | 20,734 | 24,508 | 26,708 | 24,657 | 26,782 |
4,203 | 3,349 | 3,281 | 5,258 | 6,443 | 6,638 | 29,139 | 29,388 | 24,519 | 26,746 | 23,939 | 29,754 | 33,217 | |
3,487 | 4,162 | 5,143 | 5,722 | 6,454 | 7,148 | 18,581 | 19,758 | 23,359 | 29,196 | 35,318 | 30,579 | 24,976 | |
Total Liabilities | 12,336 | 12,759 | 14,284 | 16,869 | 20,212 | 22,955 | 62,435 | 68,428 | 68,765 | 80,603 | 86,115 | 85,140 | 85,125 |
3,489 | 3,821 | 4,031 | 3,862 | 4,071 | 4,437 | 32,149 | 35,321 | 34,765 | 36,193 | 38,713 | 39,056 | 40,474 | |
CWIP | 378 | 228 | 583 | 484 | 792 | 1,319 | 1,855 | 2,073 | 2,117 | 2,501 | 2,818 | 2,965 | 1,098 |
Investments | 1,025 | 737 | 764 | 335 | 378 | 1,034 | 708 | 558 | 618 | 1,922 | 1,615 | 2,154 | 2,072 |
7,444 | 7,973 | 8,906 | 12,188 | 14,971 | 16,165 | 27,723 | 30,476 | 31,265 | 39,987 | 42,969 | 40,965 | 41,481 | |
Total Assets | 12,336 | 12,759 | 14,284 | 16,869 | 20,212 | 22,955 | 62,435 | 68,428 | 68,765 | 80,603 | 86,115 | 85,140 | 85,125 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1,699 | 1,441 | 1,409 | 1,396 | 2,585 | 2,839 | 2,356 | 8,739 | 7,212 | 6,496 | 7,751 | 1,822 | |
-765 | -427 | -463 | -1,734 | -1,022 | -2,059 | -31,282 | -2,666 | -2,426 | -3,575 | -1,354 | -2,010 | |
-72 | -1,680 | -991 | 469 | 140 | -801 | 28,893 | -2,175 | -6,713 | -1,921 | -6,227 | 164 | |
Net Cash Flow | 862 | -667 | -45 | 131 | 1,703 | -21 | -33 | 3,898 | -1,927 | 1,000 | 170 | -24 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 107 | 109 | 115 | 133 | 127 | 127 | 195 | 121 | 115 | 121 | 124 | 138 |
Inventory Days | 161 | 166 | 178 | 204 | 194 | 204 | 306 | 153 | 180 | 216 | 187 | 190 |
Days Payable | 163 | 181 | 195 | 213 | 228 | 255 | 330 | 199 | 244 | 274 | 236 | 234 |
Cash Conversion Cycle | 104 | 95 | 98 | 124 | 93 | 76 | 171 | 75 | 51 | 64 | 76 | 95 |
Working Capital Days | 100 | 85 | 78 | 113 | 99 | 107 | 168 | 72 | 69 | 73 | 68 | 93 |
ROCE % | 16% | 19% | 21% | 19% | 22% | 21% | 10% | 10% | 13% | 14% | 14% | 3% |
Documents
Announcements
-
Corporate Action - Record For Rights Issue
1d - Approval of rights issue for ₹ 3,377.74 crore.
-
Announcement under Regulation 30 (LODR)-Raising of Funds
1d - Approval of rights issue for ₹ 3,377.74 crore.
-
Board Meeting Outcome for Outcome Of Rights Issue Committee Meeting.
1d - Approval of rights issue for ₹ 3,377.74 crore.
-
Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
2d - UPL sells 8.93% stake in Advanta for $250Mn.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
2d - UPL secures $350 million investment in Advanta.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
-
Financial Year 2011
from bse
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Jan 2024TranscriptNotesPPTREC
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Oct 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Jan 2022Transcript PPT
-
Oct 2021Transcript PPT
-
Jul 2021Transcript PPT
-
May 2021Transcript PPT
-
Jan 2021Transcript PPT
-
Oct 2020Transcript PPT
-
Jul 2020Transcript PPT
-
May 2020TranscriptNotesPPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019TranscriptPPT
-
Feb 2019TranscriptPPT
-
Oct 2018Transcript PPT
-
Aug 2018Transcript PPT
-
Feb 2018TranscriptPPT
-
Nov 2017TranscriptPPT
Business Overview
UPL is a leading provider of agricultural solutions and services, with 14,000+ product registrations, a presence in ~140 countries, access to 90% of the world’s food basket. The products include Crop Protection Chemicals like Insecticides, Fungicides, Herbicides etc. also Seeds, Biosolutions. It is a 5th largest Agrochemical company globally with 43 manufacturing facilities across the globe.[1] [2]